Immunogenicity and protective efficacy of two recombinant pseudorabies viruses expressing Toxoplasma gondii SAG1 and MIC3 proteins

Veterinary Parasitology

Volumn 181, Issue 2-4, 2011, Pages 215-221

  Nie, Hao ^a,b   Fang, Rui ^a   Xiong, Bing Qing ^a   Wang, Li Xia ^a   Hu, Min ^a   Zhou, Yan Qin ^a   Zhao, Jun Long ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^b YANGTZE UNIVERSITY   (China)

Author keywords

MIC3 gene; PRV; SAG1 gene; Toxoplasma gondii; Vaccine

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 2; MIC3 PROTEIN; NEUTRALIZING ANTIBODY; PROTOZOAL PROTEIN; PSEUDORABIES VACCINE; SAG1 PROTEIN; TOXOPLASMA GONDII VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMORAL IMMUNITY; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PSEUDORABIES HERPETOVIRUS; SPLEEN CELL; TH1 CELL; TOXOPLASMA GONDII; TOXOPLASMOSIS; VIRUS RECOMBINANT;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; HERPESVIRUS 1, SUID; MICE; MICE, INBRED BALB C; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; VACCINES, SYNTHETIC;

ANIMALIA; MUS; SUID HERPESVIRUS 1; TOXOPLASMA GONDII;

EID: 80052551878     PISSN: 03044017     EISSN: 18732550     Source Type: Journal    
DOI: 10.1016/j.vetpar.2011.04.039     Document Type: Article

References (29)

1. Alexander J., Jebbari H., Bluethmann H., Satoskar A., Roberts C.W. Immunological control of Toxoplasma gondii and appropriate vaccine design. Curr. Top. Microbiol. Immunol. 1996, 219:183-195.
2. Bhopale G.M. Development of a vaccine for toxoplasmosis: current status. Microbes Infect. 2003, 5(5):457-462.
3. Chen H.C., Zhou F.C., Fang L.R., He Q.G., Wu B., Hong W.Z. Construction of TK-/gG-/LacZ+ mutant of pseudorabies virus Ea strain. Chin. J. Virol. 2001, 7(1):69-74.
4. Cong H., Gu Q.M., Yin H.E., Wang J.W., Zhao Q.L., Zhou H.Y., Li Y., Zhang J.Q. Multi-epitope DNA vaccine linked to the A2/B subunit of cholera toxin protect mice against Toxoplasma gondii. Vaccine 2008, 26(31):3913-3921.
5. Fachado A., Rodriguez A., Angel S.O., Pinto D.C., Vila I., Acosta A., Amendoeira R.R., Lannes-Vieira J. Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice. Vaccine 2003, 21(13-14):1327-1335.
6. Fang R., Nie H., Wang Z., Tu P., Zhou D., Wang L., He L., Zhou Y., Zhao J. Protective immune response in BALB/c mice induced by a suicidal DNA vaccine of the MIC3 gene of Toxoplasma gondii. Vet. Parasitol. 2009, 164(2-4):134-140.
7. Fang R., Feng H., Nie H., Wang L., Tu P., Song Q., Zhou Y., Zhao J. Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model. Vaccine 2010, 28:1803-1807.
8. Hooft van Iddekinge B.J., de Wind N., Wensvoort G., Kimman T.G., Giekens A.L., Moormann R.J. Comparison of the protective efficacy of recombinant pseudorabies viruses against pseudorabies and classical swine fever in pigs; influence of different promoters on gene expression and on protection. Vaccine 1996, 14:6-12.
9. Ismael A.B., Sekkai D., Collin C., Bout D., Mévélec M.N. The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis. Infect. Immun. 2003, 71(11):6222-6228.
10. Jiang T., Gong D., Ma L.A., Nie H., Zhou Y., Yao B., Zhao J. Evaluation of a recombinant MIC3 based latex agglutination test for the rapid serodiagnosis of Toxoplasma gondii infection in swines. Vet. Parasitol. 2008, 158(1-2):51-56.
11. Jongert E., Roberts C.W., Gargano N., Förster-Waldl E., Petersen E. Vaccines against Toxoplasma gondii: challenges and opportunities. Mem. Inst. Oswaldo Cruz 2009, 104(2):252-266.
12. Ju C.M., Fan H.Y., Tan Y.D., Liu Z.F., Xi X., Cao S.B. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2. Vet. Microbiol. 2005, 109:179-190.
13. Liu Q., Gao S., Jiang L., Shang L., Men J., Wang Z. A recombinant pseudorabies virus expressing TgSAG1 protects against challenge with the virulent Toxoplasma gondii RH strain and pseudorabies in BALB/c mice. Microbes Infect. 2008, 10(12-13):1355-1362.
14. Lv J.Q., Chen H.C., Zhao J.L., Fang L.R., He Q.G. The development of recombinant Pseudorabies virus expressing porcine parvovirus VP2 gene and the study on its biological characters. J. Virol. Sinic. 2004, 20:133-137.
15. Mishima M., Xuan X., Nishikawa Y., Makala L., Yokoyama N., Nagasawa H., Mikami T. Construction of recombinant feline herpes virus type 1 expressing Toxoplasma gondii surface antigen 1. Mol. Biochem. Parasitol. 2001, 117(1):103-106.
16. Nielsen H.V., Lauemoller S.L., Christiansen L., Buus S., Fomsgaard A., Petersen E. Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene. Infect. Immun. 1999, 67:6356-6363.
17. Osorio Y., Ghiasi H. Recombinant herpes simplex virus type 1 (HSV-1) codelivering interleukin-12p35 as a molecular adjuvant enhances the protective immune response against ocular HSV-1 challenge. J. Virol. 2005, 79:3297-3308.
18. Salwa A. A natural outbreak of Aujeszky's disease in farm animals. Pol. J. Vet. Sci. 2004, 7(4):261-266.
19. Siachoque H., Guzman F., Burqos J., Patarroyo M.E., Gomez Marin J.E. Toxoplasma gondii: immunogenicity and protection by SAG1 peptides in a murine model. Exp. Parasitol. 2006, 114:62-65.
20. Souza A.P., Haut L., Reyes-Sandoval A., Pinto A.R. Recombinant viruses as vaccines against viral diseases. Braz. J. Med. Biol. Res. 2005, 38:509-522.
21. Tenter A.M., Heckeroth A.R., Weiss L.M. Toxoplasma gondii: from animals to humans. Int. J. Parasitol. 2000, 30(12-13):1217-1258.
22. Veits J., Luschow D., Kindermann K., Werner O., Teifke J.P., Mettenleiter T.C. Deletion of the non-essential UL0 gene of infectious laryngotracheitis (ILT) virus leads to attenuation in chickens, and UL0 mutants expressing influenza virus haemagglutinin (H7) protect against ILT and fowl plague. J. Gen. Virol. 2003, 84:3343-3352.
23. Wang H., He S., Yao Y., Cong H., Zhao H., Li T., Zhu X.Q. Toxoplasma gondii: protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice. Exp. Parasitol. 2009, 122(3):226-232.
24. Wang H., Liu Q., Liu K., Zhong W., Gao S., Jiang L., An N. Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii. Parasitol. Int. 2007, 56(4):263-268.
25. Wang J.P., Zhao J.L., Jiang T., Zhou Y.Q., Liu Q., Fu Y., Yao B.A. Cloning and prokaryotic expression of Toxoplasma gondii SAG1 gene. J. Huazhong Agric. Univ. 2006, 25(1):9-12.
26. Xu G., Xu X., Li Z., He Q., Wu B., Sun S., Chen H. Construction of recombinant pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14-14-2) virus and its safety and immunogenicity. Vaccine 2004, 22(15-16):1846-1853.
27. Xue M., He S., Cui Y., Yao Y., Wang H. Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii. Parasitol. Int. 2008, 57(4):424-429.
28. Xue M., He S., Zhang J., Cui Y., Yao Y., Wang H. Comparison of cholera toxin A2/B and murine interleukin-12 as adjuvants of Toxoplasma multi-antigenic SAG1-ROP2 DNA vaccine. Exp. Parasitol. 2008, 119(3):352-357.
29. Zhou H., Gu Q., Zhao Q., Zhang J., Cong H., Li Y., He S. Toxoplasma gondii: expression and characterization of a recombinant protein containing SAG1 and GRA2 in Pichia pastoris. Parasitol. Res. 2007, 100:829-835.